Health Trials

A Study on the Preference of Risperidone Dosage Forms

ConditionsSchizophreniaBipolar Affective DisorderAutism Spectrum DisorderConduct DisorderMental Retardation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShanghai Mental Health Center

About this trial

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Eligibility criteria

Qualifiers

Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.

Disqualifiers

Have difficulty reading and understanding Chinese or refuse to participate in the study.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group

Sponsors and collaborators

Shanghai Mental Health Center

Lead sponsor

Source ClinicalTrials.gov